LLY Competitors
Eli Lilly and Company
$1,414.17
+$60.17(+4.44%)
69
Overall
45
Value
91
Tech
71
Quality
Market Cap
$1.33T
Volume
1.63M
52W Range
$850.51 - $1,453.00
Target Price
$1,441.93
LLY competitors: BMY, MRK, JNJ, PFE, SNY. Eli Lilly and Company is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
LLY Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| BMY Bristol-Myers Squibb Company | $62.14 | $127.02B | $6.43 | 4.06% | 69 |
| MRK Merck & Co., Inc. | $146.73 | $361.73B | $2.78 | 2.32% | 69 |
| JNJ Johnson & Johnson | $276.22 | $664.95B | $11.12 | 1.91% | 70 |
| PFE Pfizer Inc. | $29.39 | $167.52B | $3.04 | 4.39% | 74 |
| SNY Sanofi | $47.04 | $114.72B | $5.00 | 5.14% | 79 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LLY | $1,414.17 | +4.4% | 1.63M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |